Abstract
Ixazomib-Lenalidomide-Dexamethasone (IRd) Consolidation Following Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Large Multi-Center Phase II Trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have